Natures Sunshine Products Inc
NASDAQ:NATR
Intrinsic Value
Natures Sunshine Products, Inc. engages in the manufacturing and direct selling of nutritional and personal care products. [ Read More ]
The intrinsic value of one NATR stock under the Base Case scenario is 15.45 USD. Compared to the current market price of 19.77 USD, Natures Sunshine Products Inc is Overvalued by 22%.
Valuation Backtest
Natures Sunshine Products Inc
Run backtest to discover the historical profit from buying and selling NATR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Natures Sunshine Products Inc
Current Assets | 165.8m |
Cash & Short-Term Investments | 82.4m |
Receivables | 8.8m |
Other Current Assets | 74.6m |
Non-Current Assets | 84m |
Long-Term Investments | 747k |
PP&E | 58.4m |
Other Non-Current Assets | 24.8m |
Current Liabilities | 76.8m |
Accounts Payable | 7.9m |
Accrued Liabilities | 60.6m |
Other Current Liabilities | 8.2m |
Non-Current Liabilities | 19m |
Other Non-Current Liabilities | 19m |
Earnings Waterfall
Natures Sunshine Products Inc
Revenue
|
445.3m
USD
|
Cost of Revenue
|
-124.2m
USD
|
Gross Profit
|
321.1m
USD
|
Operating Expenses
|
-296.7m
USD
|
Operating Income
|
24.4m
USD
|
Other Expenses
|
-9.4m
USD
|
Net Income
|
15.1m
USD
|
Free Cash Flow Analysis
Natures Sunshine Products Inc
What is Free Cash Flow?
NATR Profitability Score
Profitability Due Diligence
Natures Sunshine Products Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Natures Sunshine Products Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
NATR Solvency Score
Solvency Due Diligence
Natures Sunshine Products Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Score
Natures Sunshine Products Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NATR Price Targets Summary
Natures Sunshine Products Inc
According to Wall Street analysts, the average 1-year price target for NATR is 24.48 USD with a low forecast of 24.24 USD and a high forecast of 25.2 USD.
Ownership
NATR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
NATR Price
Natures Sunshine Products Inc
Average Annual Return | 9.97% |
Standard Deviation of Annual Returns | 50.21% |
Max Drawdown | -62% |
Market Capitalization | 373.2m USD |
Shares Outstanding | 19 395 000 |
Percentage of Shares Shorted | 0.7% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Natures Sunshine Products, Inc. engages in the manufacturing and direct selling of nutritional and personal care products. The company is headquartered in Lehi, Utah and currently employs 850 full-time employees. The company went IPO on 2009-06-25. The firm has four segments: Asia, Europe, North America, and Latin America and Other. Its segments operate under the Nature's Sunshine Products and Synergy WorldWide brands. Its products are grouped into six principal categories, such as general health, immune, cardiovascular, digestive, personal care and weight management. Its general health category is a combination of assorted health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. Its immune category offers products that support and strengthen the human immune system. Its cardiovascular category is designed to offer products that combine a variety of superior heart health ingredients to give the cardiovascular system optimum support.
Contact
IPO
Employees
Officers
The intrinsic value of one NATR stock under the Base Case scenario is 15.45 USD.
Compared to the current market price of 19.77 USD, Natures Sunshine Products Inc is Overvalued by 22%.